Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada.
作者信息
Hamilou Zineb, North Scott, Canil Christina, Wood Lori, Hotte Sebastien, Sridhar Srikala S, Soulières Denis, Latour Mathieu, Taussky Daniel, Kassouf Wassim, Blais Normand
机构信息
Division of Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Division of Medical Oncology, University of Alberta Cross Cancer Institute, Edmonton, AB, Canada.
出版信息
Can Urol Assoc J. 2020 Mar;14(3):E57-E64. doi: 10.5489/cuaj.5946. Epub 2019 Jul 23.
Abstract
摘要
相似文献
1
Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada.脐尿管癌的管理：加拿大泌尿外科协会和加拿大泌尿生殖系统医学肿瘤学家的共识声明
Can Urol Assoc J. 2020 Mar;14(3):E57-E64. doi: 10.5489/cuaj.5946. Epub 2019 Jul 23.
2
Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.加拿大泌尿外科协会/加拿大泌尿生殖系统医学肿瘤学家共识声明：不可切除的局部晚期和转移性尿路上皮癌的管理
Can Urol Assoc J. 2019 Oct;13(10):318-327. doi: 10.5489/cuaj.6015.
3
Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).阴茎癌的管理：加拿大泌尿生殖医学肿瘤学家协会（CAGMO）的共识声明。
Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E797-811. doi: 10.5489/cuaj.1794.
4
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.共识声明：第16届加拿大西部胃肠道癌年度共识会议；萨斯喀彻温省萨斯卡通；2014年9月5日至6日。
Curr Oncol. 2015 Apr;22(2):e113-23. doi: 10.3747/co.22.2362.
5
Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.加拿大肌肉浸润性膀胱癌的治疗：一项针对泌尿生殖系统肿瘤内科医生和泌尿科医生的调查。
Can Urol Assoc J. 2014 Sep;8(9-10):309-16. doi: 10.5489/cuaj.2111.
6
Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian Association of Medical Oncologists survey report.COVID-19 对加拿大肿瘤学家和癌症护理的影响：加拿大肿瘤学家协会调查报告。
Curr Oncol. 2020 Apr;27(2):71-74. doi: 10.3747/co.27.6643. Epub 2020 May 1.
7
Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care.明智选择加拿大癌症清单：癌症护理中应避免的十种低价值或有害做法。
J Oncol Pract. 2015 May;11(3):e296-303. doi: 10.1200/JOP.2015.004325.
8
Consensus document: recommendations for optimal surgical wait times for patients with urological malignancies.共识文件：关于泌尿系统恶性肿瘤患者最佳手术等待时间的建议
Can J Urol. 2006 Jun;13 Suppl 3:62-4.
9
Report from the 19th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29-30 September 2017.第19届加拿大西部胃肠癌共识会议报告；马尼托巴省温尼伯；2017年9月29日至30日。
Curr Oncol. 2018 Aug;25(4):275-284. doi: 10.3747/co.25.4109. Epub 2018 Aug 14.
10
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).膀胱小细胞癌的管理：加拿大泌尿生殖系统医学肿瘤学家协会（CAGMO）的共识指南。
Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E44-56. doi: 10.5489/cuaj.220.
引用本文的文献
1
Robot‑assisted laparoscopic partial cystectomy for urachal carcinoma: A case report.机器人辅助腹腔镜下脐尿管癌部分膀胱切除术：一例报告
Oncol Lett. 2025 Apr 1;29(5):257. doi: 10.3892/ol.2025.15003. eCollection 2025 May.
2
Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancer.脐尿管癌中可靶向突变与肿瘤微环境的综合分析
NPJ Precis Oncol. 2025 Jan 11;9(1):12. doi: 10.1038/s41698-024-00795-4.
3
Surgical treatment of urachal adenocarcinoma with lung metastasis: A case report and literature review.脐尿管腺癌伴肺转移的外科治疗：一例报告及文献复习
Thorac Cancer. 2024 Dec;15(35):2509-2513. doi: 10.1111/1759-7714.15481. Epub 2024 Oct 27.
4
A remnant never forgotten: the utility of circulating tumor DNA in treatment guidance of urachal cancer.一个永远不会被遗忘的残余物：循环肿瘤DNA在脐尿管癌治疗指导中的效用。
Ther Adv Med Oncol. 2024 Feb 28;16:17588359241230743. doi: 10.1177/17588359241230743. eCollection 2024.
5
The Management of a Case With Mucin-Producing Adenocarcinoma Originating From the Urachus.一例源自脐尿管的黏液腺癌病例的管理
Cureus. 2024 Jan 16;16(1):e52376. doi: 10.7759/cureus.52376. eCollection 2024 Jan.
6
Regular gastroscopy and colonoscopy during the evaluation of urachal cancer: do we really need them?在脐尿管癌的评估中，是否需要常规进行胃镜和结肠镜检查？
BMC Cancer. 2023 Nov 27;23(1):1156. doi: 10.1186/s12885-023-11531-9.
7
Urachal Adenocarcinoma: a Case Report and Review of the Literature.脐尿管腺癌：一例报告及文献复习
Indian J Surg Oncol. 2023 Sep;14(3):677-681. doi: 10.1007/s13193-023-01736-6. Epub 2023 Mar 27.
8
Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy.脐尿管腺癌：一种采用FOLFOX化疗方案治疗的罕见原发性癌症。
Cureus. 2023 Aug 21;15(8):e43849. doi: 10.7759/cureus.43849. eCollection 2023 Aug.
9
Primary urachal leiomyosarcoma: a case report and literature review of clinical, pathological, and medical imaging features.原发性脐尿管平滑肌肉瘤：一例病例报告及临床、病理和医学影像特征的文献综述
Front Oncol. 2023 Aug 17;13:1228178. doi: 10.3389/fonc.2023.1228178. eCollection 2023.
10
Urachal xanthogranuloma: a rare but important case presenting as a urachal mass.脐尿管黄肉芽肿：一种罕见但重要的病例，表现为脐尿管肿块。
BMC Urol. 2023 Aug 3;23(1):132. doi: 10.1186/s12894-023-01297-4.
本文引用的文献
1
Genetics and biological markers in urachal cancer.脐尿管癌中的遗传学与生物标志物
Transl Androl Urol. 2016 Oct;5(5):655-661. doi: 10.21037/tau.2016.04.01.
2
Malignant urachal neoplasms: A population-based study and systematic review of literature.恶性脐尿管肿瘤：一项基于人群的研究及文献系统综述
Urol Oncol. 2017 Jan;35(1):33.e11-33.e19. doi: 10.1016/j.urolonc.2016.07.021. Epub 2016 Sep 1.
3
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.脐尿管癌中KRAS、NRAS、BRAF、EGFR和PIK3CA基因的突变：发生率及预后意义。
Oncotarget. 2016 Jun 28;7(26):39293-39301. doi: 10.18632/oncotarget.9828.
4
Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.脐尿管癌的临床、预后及治疗方面——1010例病例的综合综述与荟萃分析
Urol Oncol. 2016 Sep;34(9):388-98. doi: 10.1016/j.urolonc.2016.04.012. Epub 2016 Jun 3.
5
Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition.脐尿管癌与结直肠癌存在共同的基因组改变，且可能对表皮生长因子抑制有反应。
Eur Urol. 2016 Nov;70(5):771-775. doi: 10.1016/j.eururo.2016.04.037. Epub 2016 May 10.
6
Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.脐尿管源性上皮性肿瘤的病理诊断与分类的进展
Adv Anat Pathol. 2016 Mar;23(2):71-83. doi: 10.1097/PAP.0000000000000110.
7
Urachal carcinoma: a pathologic and clinical study of 46 cases.脐尿管癌：46例病例的病理与临床研究
Hum Pathol. 2015 Dec;46(12):1808-14. doi: 10.1016/j.humpath.2015.07.021. Epub 2015 Aug 12.
8
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.错配修复缺陷肿瘤中的程序性死亡受体-1阻断
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.
9
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal Cancer.脐尿管癌姑息化疗的治疗结果及相关性
Chemotherapy. 2014;60(2):73-80. doi: 10.1159/000368071. Epub 2014 Nov 29.
10
High-stage urachal adenocarcinoma can be associated with microsatellite instability and KRAS mutations.高级脐尿管腺癌可伴有微卫星不稳定和 KRAS 突变。
Hum Pathol. 2014 Feb;45(2):327-30. doi: 10.1016/j.humpath.2013.09.008. Epub 2013 Oct 3.
Zotero 插件